Literature DB >> 29453419

A randomized controlled study of a consent intervention for participating in an NIH genome sequencing study.

Erin Turbitt1, Paola P Chrysostomou2, Holly L Peay3, Alexis R Heidlebaugh1, Lawrence M Nelson2, Barbara B Biesecker4.   

Abstract

To make an informed choice to participate in a genome sequencing study that may yield primary and secondary findings, one understands relevant information in the context of personal values. Consent forms to enroll in a sequencing study can be long and complex. The efficacy of the professional encounter to consider the information contained in the consent form and make an informed choice is unknown. Women diagnosed with primary ovarian insufficiency and eligible for a sequencing study were randomized to participate in one of two encounters with a genetic counselor: a consent intervention using a lower literacy, less dense form or a standard consent encounter. Data were complete for 188 of 225 participants. The average time was 32 min for the intervention and 34 min for the standard, with the intervention encounter generating more questions from participants. At six weeks following consent, no differences were found between the two groups in primary outcomes: 'sequencing benefits' knowledge (d  =  0.12, 95%CI: -0.03,0.27), 'sequencing limitations' knowledge (d  =  0.04, 95%CI: -0.13,0.21), expected personal benefits (d  =  -0.01, 95%CI: -0.26,0.23), and decisional conflict (d =  0.04, 95%CI: -0.14,0.21). Although intentions to learn secondary variants were high, only 60% (113) of participants made an informed choice as defined by the multi-dimensional model of informed choice. We found that a modified consent intervention was as effective as a standard encounter and led to more interaction. Our data suggest that making decisions to receive secondary findings may be particularly challenging and in need of further investigation to achieve informed choice.

Entities:  

Mesh:

Year:  2018        PMID: 29453419      PMCID: PMC5945708          DOI: 10.1038/s41431-018-0105-7

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  21 in total

Review 1.  Diagnostic clinical genome and exome sequencing.

Authors:  Leslie G Biesecker; Robert C Green
Journal:  N Engl J Med       Date:  2014-06-19       Impact factor: 91.245

2.  Informed consent for exome sequencing research in families with genetic disease: the emerging issue of incidental findings.

Authors:  Amanda L Bergner; Juli Bollinger; Karen S Raraigh; Crystal Tichnell; Brittney Murray; Carrie Lynn Blout; Aida Bytyci Telegrafi; Cynthia A James
Journal:  Am J Med Genet A       Date:  2014-09-22       Impact factor: 2.802

3.  Validation of a decisional conflict scale.

Authors:  A M O'Connor
Journal:  Med Decis Making       Date:  1995 Jan-Mar       Impact factor: 2.583

4.  Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeq study.

Authors:  Flavia M Facio; Haley Eidem; Tyler Fisher; Stephanie Brooks; Amy Linn; Kimberly A Kaphingst; Leslie G Biesecker; Barbara B Biesecker
Journal:  Eur J Hum Genet       Date:  2012-08-15       Impact factor: 4.246

5.  Experiences with obtaining informed consent for genomic sequencing.

Authors:  Barbara A Bernhardt; Myra I Roche; Denise L Perry; Sarah R Scollon; Ashley N Tomlinson; Debra Skinner
Journal:  Am J Med Genet A       Date:  2015-07-21       Impact factor: 2.802

6.  The multi-dimensional measure of informed choice: a validation study.

Authors:  Susan Michie; Elizabeth Dormandy; Theresa M Marteau
Journal:  Patient Educ Couns       Date:  2002-09

7.  Characterizing Participants in the ClinSeq Genome Sequencing Cohort as Early Adopters of a New Health Technology.

Authors:  Katie L Lewis; Paul K J Han; Gillian W Hooker; William M P Klein; Leslie G Biesecker; Barbara B Biesecker
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

8.  A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group.

Authors:  H Bleiberg; G Decoster; A de Gramont; P Rougier; A Sobrero; A Benson; B Chibaudel; J Y Douillard; C Eng; C Fuchs; M Fujii; R Labianca; A K Larsen; E Mitchell; H J Schmoll; D Sprumont; J Zalcberg
Journal:  Ann Oncol       Date:  2017-05-01       Impact factor: 32.976

9.  Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trial.

Authors:  Salma Shickh; Marc Clausen; Chloe Mighton; Selina Casalino; Esha Joshi; Emily Glogowski; Kasmintan A Schrader; Adena Scheer; Christine Elser; Seema Panchal; Andrea Eisen; Tracy Graham; Melyssa Aronson; Kara M Semotiuk; Laura Winter-Paquette; Michael Evans; Jordan Lerner-Ellis; June C Carroll; Jada G Hamilton; Kenneth Offit; Mark Robson; Kevin E Thorpe; Andreas Laupacis; Yvonne Bombard
Journal:  BMJ Open       Date:  2018-04-26       Impact factor: 2.692

10.  Navigating the research-clinical interface in genomic medicine: analysis from the CSER Consortium.

Authors:  Susan M Wolf; Laura M Amendola; Jonathan S Berg; Wendy K Chung; Ellen Wright Clayton; Robert C Green; Julie Harris-Wai; Gail E Henderson; Gail P Jarvik; Barbara A Koenig; Lisa Soleymani Lehmann; Amy L McGuire; Pearl O'Rourke; Carol Somkin; Benjamin S Wilfond; Wylie Burke
Journal:  Genet Med       Date:  2017-08-31       Impact factor: 8.822

View more
  7 in total

1.  ORCA, a values-based decision aid for selecting additional findings from genomic sequencing in adults: Efficacy results from a randomized trial.

Authors:  Elizabeth G Liles; Michael C Leo; Amanda S Freed; Kathryn M Porter; Jamilyn M Zepp; Tia L Kauffman; Erin Keast; Carmit K McMullen; Inga Gruß; Barbara B Biesecker; Kristin R Muessig; Donna J Eubanks; Laura M Amendola; Michael O Dorschner; Bradley A Rolf; Gail P Jarvik; Katrina A B Goddard; Benjamin S Wilfond
Journal:  Genet Med       Date:  2022-05-06       Impact factor: 8.864

Review 2.  Views on genomic research result delivery methods and informed consent: a review.

Authors:  Danya F Vears; Joel T Minion; Stephanie J Roberts; James Cummings; Mavis Machirori; Madeleine J Murtagh
Journal:  Per Med       Date:  2021-04-06       Impact factor: 2.512

Review 3.  Informed Consent in the Genomics Era.

Authors:  Shannon Rego; Megan E Grove; Mildred K Cho; Kelly E Ormond
Journal:  Cold Spring Harb Perspect Med       Date:  2020-08-03       Impact factor: 5.159

4.  Challenges to informed consent for exome sequencing: A best-worst scaling experiment.

Authors:  Rachel H Gore; John F P Bridges; Julie S Cohen; Barbara B Biesecker
Journal:  J Genet Couns       Date:  2019-09-25       Impact factor: 2.717

5.  The role of digital tools in the delivery of genomic medicine: enhancing patient-centered care.

Authors:  Salma Shickh; Sara A Rafferty; Marc Clausen; Rita Kodida; Chloe Mighton; Seema Panchal; Justin Lorentz; Thomas Ward; Nicholas Watkins; Christine Elser; Andrea Eisen; June C Carroll; Emily Glogowski; Kasmintan A Schrader; Jordan Lerner-Ellis; Raymond H Kim; David Chitayat; Cheryl Shuman; Yvonne Bombard
Journal:  Genet Med       Date:  2021-03-02       Impact factor: 8.864

6.  Shortened consent forms for genome-wide sequencing: Parent and provider perspectives.

Authors:  Emma C Hitchcock; Causes Study; Alison M Elliott
Journal:  Mol Genet Genomic Med       Date:  2020-05-08       Impact factor: 2.183

7.  Old Challenges or New Issues? Genetic Health Professionals' Experiences Obtaining Informed Consent in Diagnostic Genomic Sequencing.

Authors:  Danya F Vears; Pascal Borry; Julian Savulescu; Julian J Koplin
Journal:  AJOB Empir Bioeth       Date:  2020-10-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.